Angiotensin-converting Enzyme Inhibition Down-regulates the Pro-atherogenic Chemokine Receptor 9 (CCR9)-Chemokine Ligand 25 (CCL25) Axis

Many experimental and clinical studies suggest a relationship between enhanced angiotensin II release by the angiotensin-converting enzyme (ACE) and the pathophysiology of atherosclerosis. The atherosclerosis-enhancing effects of angiotensin II are complex and incompletely understood. To identify an...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Abd Alla, Joshua, Langer, Andreas, Elzahwy, Sherif S., Arman-Kalcek, Gökhan, Streichert, Thomas, Quitterer, Ursula
Médium: Artigo
Jazyk:Inglês
Vydáno: American Society for Biochemistry and Molecular Biology 2010
Témata:
Molecular Bases of Disease
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2906340/
https://ncbi.nlm.nih.gov/pubmed/20504763
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1074/jbc.M110.117481
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky